Molecular mechanisms of severe acute respiratory syndrome (SARS)

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Groneberg, David A ^a   Hilgenfeld, Rolf ^b   Zabel, Peter ^b,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Coronavirus; Molecular mechanisms; SARS; Severe Acute Respiratory Syndrome; Therapy; Vaccination

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CONSENSUS INTERFERON; DIPEPTIDYL CARBOXYPEPTIDASE; EPITOPE BASED VACCINE; LEPTIN RECEPTOR; LIVE VACCINE; MESSENGER RNA; METALLOPROTEINASE; METHYLPREDNISOLONE; MICROSOMAL AMINOPEPTIDASE; PROTEINASE INHIBITOR; RECOMBINANT SUBUNIT VACCINE; RECOMBINANT VECTORED VACCINE; RUPINTRIVIR; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VIRUS VACCINE; WHOLE KILLED VACCINE;

AGE DISTRIBUTION; BINDING AFFINITY; CELL SPECIFICITY; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE DURATION; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; GENOME ANALYSIS; HEALTH HAZARD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFECTION CONTROL; INFECTION RISK; MORBIDITY; MORTALITY; PATHOGENESIS; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STRAIN DIFFERENCE; TARGET CELL; VACCINATION; VIRUS CLASSIFICATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; BLOOD; IMMUNOLOGY; METABOLISM; VIROLOGY;

ANIMALS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL PROTEINS; VIRAL VACCINES;

EID: 21744441372     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-6-8     Document Type: Review

References (125)

1. Groneberg DA, Zhang L, Welte T, Zabel P, Chung KF: Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM 2003, 96:845-852.
2. Groneberg DA, Fischer A, Chung KF, Daniel H: Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. Am J Respir Cell Mol Biol 2004, 30:251-260.
3. Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A: Fundamentals of pulmonary drug delivery. Respir Med 2003, 97:382-387.
4. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361:1319-1325.
5. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003, 348:1967-1976.
6. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003, 348:1953-1966.
7. Reilley B, Van Herp M, Sermand D, Dentico N: SARS and Carlo Urbani. N Engl J Med 2003, 348:1951-1952.
8. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003, 361:1730-1733.
9. Oxford JS, Bossuyt S, Lambkin R: A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. Immunology 2003, 109:326-328.
10. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003, 362:263-270.
11. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD: Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423:240.
12. Siddell S, Wege H, ter Meulen V: The structure and replication of coronaviruses. Curr Top Microbiol Immunol 1982, 99:131-163.
13. Wege H, Siddell S, ter Meulen V: The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol 1982, 99:165-200.
14. Cavanagh D: Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 1997, 142:629-633.
15. Lai MM, Cavanagh D: The molecular biology of coronaviruses. Adv Virus Res 1997, 48:1-100.
16. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS, Robertson AG, Schein JE, Siddiqui A, Smailus DE, Stott JM, Yang GS, Plummer F, Andonov A, Artsob H, Bastien N, Bernard K, Booth TF, Bowness D, Czub M, Drebot M, Fernando L, Flick R, Garbutt M, Gray M, Grolla A, Jones S, Feldmann H, Meyers A, Kabani A, Li Y, Normand S, Stroher U, Tipples GA, Tyler S, Vogrig R, Ward D, Watson B, Brunham RC, Krajden M, Petric M, Skowronski DM, Upton C, Roper RL: The Genome sequence of the SARS-associated coronavirus. Science 2003, 300:1399-1404.
17. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
18. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM, Wong KL, Chan KW, Lim W, Shortridge KF, Yuen KY, Peiris JS, Poon LL: Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302:276-278.
19. Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk HD, Rappuoli R: SARS - beginning to understand a new virus. Nat Rev Microbiol 2003, 1:209-218.
20. Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JS, Lim W, Osterhaus AD: Virology: SARS virus infection of cats and ferrets. Nature 2003, 425:915.
21. Kamahora T, Soe LH, Lai MM: Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43. Virus Res 1989, 12:1-9.
22. Chouljenko VN, Kousoulas KG, Lin X, Storz J: Nucleotide and predicted amino acid sequences of all genes encoded by the 3′ genomic portion (9.5 kb) of respiratory bovine coronaviruses and comparisons among respiratory and enteric coronaviruses. Virus Genes 1998, 17:33-42.
23. Guy JS, Breslin JJ, Breuhaus B, Vivrette S, Smith LG: Characterization of a Coronavirus Isolated from a Diarrheic Foal. J Clin Microbiol 2000, 38:4523-4526.
24. Horzinek MC: Molecular evolution of corona- and toroviruses. Adv Exp Med Biol 1999, 473:61-72.
25. Gibbs AJ, Gibbs MJ, Armstrong JS: The phylogeny of SARS coronavirus. Arch Virol 2004, 149:621-624.
26. Eickmann M, Becker S, Klenk HD, Doerr HW, Stadler K, Censini S, Guidotti S, Masignani V, Scarselli M, Mora M, Donati C, Han JH, Song HC, Abrignani S, Covacci A, Rappuoli R: Phylogeny of the SARS coronavirus. Science 2003, 302:1504-1505.
27. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE: Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 2003, 331:991-1004.
28. Consortium CSME: Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004, 303:1666-1669.
29. Thiel V, Ivanov KA, Putics A, Hertzig T, Schelle B, Bayer S, Weissbrich B, Snijder EJ, Rabenau H, Doerr HW, Gorbalenya AE, Ziebuhr J: Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 2003, 84:2305-2315.
30. Gorbalenya AE, Koonin EV, Donchenko AP, Blinov VM: Coronavirus genome: prediction of putative functional domains in the non-structural polyprotein by comparative amino acid sequence analysis. Nucleic Acids Res 1989, 17:4847-4861.
31. Lai MM: SARS Virus: The Beginning of the Unraveling of a New Coronavirus. J Biomed Sci 2003, 10:664-675.
32. Ortego J, Sola I, Almazan F, Ceriani JE, Riquelme C, Balasch M, Plana J, Enjuanes L: Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence. Virology 2003, 308:13-22.
33. Spiga O, Bernini A, Ciutti A, Chiellini S, Menciassi N, Finetti F, Causarono V, Anselmi F, Prischi F, Niccolai N: Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. Biochem Biophys Res Commun 2003, 310:78-83.
34. Wu XD, Shang B, Yang RF, Yu H, Ma ZH, Shen X, Ji YY, Lin Y, Wu YD, Lin GM, Tian L, Gan XQ, Yang S, Jiang WH, Dai EH, Wang XY, Jiang HL, Xie YH, Zhu XL, Pei G, Li L, Wu JR, Sun B: The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. Cell Res 2004, 14:400-406.
35. Godet M, Grosclaude J, Delmas B, Laude H: Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J Virol 1994, 68:8008-8016.
36. Kubo H, Yamada YK, Taguchi F: Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol 1994, 68:5403-5410.
37. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ: The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 2003, 77:8801-8811.
38. Liu S, Xiao G, Chen Y, He Y, Niu J, Escalante CR, Xiong H, Farmar J, Debnath AK, Tien P, Jiang S: Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet 2004, 363:938-947.
39. Tripet B, Howard MW, Jobling M, Holmes RK, Holmes KV, Hodges RS: Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 2004, 279:20836-20849.
40. Xu Y, Liu Y, Lou Z, Qin L, Li X, Bai Z, Pang H, Tien P, Gao GF, Rao Z: Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem 2004, 279:30514-30522.
41. Vennema H, Godeke GJ, Rossen JW, Voorhout WF, Horzinek MC, Opstelten DJ, Rottier PJ: Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J 1996, 15:2020-2028.
42. Bos EC, Luytjes W, van der Meulen HV, Koerten HK, Spaan WJ: The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology 1996, 218:52-60.
43. Antia R, Regoes RR, Koella JC, Bergstrom CT: The role of evolution in the emergence of infectious diseases. Nature 2003, 426:658-661.
44. Huang J, Brieba LG, Sousa R: Misincorporation by wild-type and mutant T7 RNA polymerases: identification of interactions that reduce misincorporation rates by stabilizing the catalytically incompetent open conformation. Biochemistry 2000, 39:11571-11580.
45. Ruan YJ, Wei CL, Ee AL, Vega VB, Thoreau H, Su ST, Chia JM, Ng P, Chiu KP, Lim L, Zhang T, Peng CK, Lin EO, Lee NM, Yee SL, Ng LF, Chee RE, Stanton LW, Long PM, Liu ET: Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003, 361:1779-1785.
46. Herrewegh AAPM, Mahler M, Hedrich HJ, Haagmans BL, Egberink HF, Horzinek MC, Rottier PJM, de Groot RJ: Persistence and Evolution of Feline Coronavirus in a Closed Cat-Breeding Colony*1. Virology 1997, 234:349-363.
47. Knobler RL, Haspel MV, Oldstone MB: Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease. J Exp Med 1981, 153:832-843.
48. Underdahl NR, Mebus CA, Torres-Medina A: Recovery of transmissible gastroenteritis virus from chronically infected experimental pigs. Am J Vet Res 1975, 36:1473-1476.
49. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson RM: Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003, 361:1761-1766.
50. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJ: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003, 348:1986-1994.
51. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS: Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003, 289:2801-2809.
52. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361:1767-1772.
53. Bitnun A, Allen U, Heurter H, King SM, Opavsky MA, Ford-Jones EL, Matlow A, Kitai I, Tellier R, Richardson S, Manson D, Babyn P, Read S: Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003, 112:e261.
54. Chiu, Wk, Cheung, Pc, Ng, Kl, Ip, Pl, Sugunan, Vk, Luk, Dc, Ma, Lc, Chan, Bh, Lo, Lai WM: Severe acute respiratory syndrome in children: Experience in a regional hospital in Hong Kong. Pediatr Crit Care Med 2003, 4:279-283.
55. Sit SC, Yau EK, Lam YY, Ng DK, Fong NC, Hui YW, Cheng WF, Leung CW, Chiu MC: A young infant with severe acute respiratory syndrome. Pediatrics 2003, 112:e257.
56. Tsou IY, Loh LE, Kaw GJ, Chan I, Chee TS: Severe acute respiratory syndrome (SARS) in a paediatric cluster in Singapore. Pediatr Radiol 2003.
57. Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, Li AM, Fong NC, Ng PC, Chiu MC, Li CK, Tam JS, Fok TF: Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003, 361:1701-1703.
58. Wong GW, Li AM, Ng PC, Fok TF: Severe acute respiratory syndrome in children. Pediatr Pulmonol 2003, 36:261-266.
59. Ng PC, Leung CW, Chiu WK, Wong SF, Hon EK: SARS in newborns and children. Biol Neonate 2004, 85:293-298.
60. Li AM, Chan CH, Chan DF: Long-term sequelae of SARS in children. Paediatr Respir Rev 2004, 5:296-299.
61. Liu C, Xu HY, Liu DX: Induction of Caspase-Dependent Apoptosis in Cultured Cells by the Avian Coronavirus Infectious Bronchitis Virus. J Virol 2001, 75:6402-6409.
62. Lavi E, Wang Q, Weiss SR, Gonatas NK: Syncytia formation induced by coronavirus infection is associated with fragmentation and rearrangement of the Golgi apparatus. Virology 1996, 221:325-334.
63. Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, Leung CB, Rainer TH, Cameron P, Chung SS, Sung JJ, Ahuja AT: Thin-Section CT in Patients with Severe Acute Respiratory Syndrome Following Hospital Discharge: Preliminary Experience. Radiology 2003, 228:810-815.
64. Ning Q, Liu M, Kongkham P, Lai MMC, Marsden PA, Tseng J, Pereira B, Belyavskyi M, Leibowitz J, Phillips MJ, Levy G: The Nucleocapsid Protein of Murine Hepatitis Virus Type 3 Induces Transcription of the Novel fgl2 Prothrombinase Gene. J Biol Chem 1999, 274:9930-9936.
65. Marten NW, Stohlman SA, Bergmann CC: MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol 2001, 14:1-18.
66. Weiss RC, Scott FW: Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981, 4:175-189.
67. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003, 361:1773-1778.
68. Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, McEvoy CP, Hayden CD, Fukuoka J, Taubenberger JK, Travis WD: Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore. Hum Pathol 2003, 34:729.
69. Tsang K, Zhong NS: SARS: pharmacotherapy. Respirology 2003, 8 Suppl:S25-30.
70. Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan-Yeung M, Tsang KW: High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 2003, 168:1449-1456.
71. Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, Deif H, LaMere EA, Chang M, Kain KC, Farcas GA, Ferguson P, Latchford M, Levy G, Dennis JW, Lai EK, Fish EN: Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003, 290:3222-3228.
72. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR: Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol 1998, 72:9628-9636.
73. Ballesteros ML, Sanchez CM, Enjuanes L: Two Amino Acid Changes at the N-Terminus of Transmissible Gastroenteritis Coronavirus Spike Protein Result in the Loss of Enteric Tropism. Virology 1997, 227:378-388.
74. de Haan CA, Masters PS, Shen X, Weiss S, Rottier PJ: The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 2002, 296:177-189.
75. An S, Chen CJ, Yu X, Leibowitz JL, Makino S: Induction of Apoptosis in Murine Coronavirus-Infected Cultured Cells and Demonstration of E Protein as an Apoptosis Inducer. J Virol 1999, 73:7853-7859.
76. Charley B, Laude H: Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1. J Virol 1988, 62:8-11.
77. Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, Cai J, Li X, Kang W, Weng D, Lu Y, Wu D, He L, Yao K: The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003, 200:282-289.
78. Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjostrom H, Noren O, Laude H: Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992, 357:417-420.
79. Williams RK, Jiang GS, Holmes KV: Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A 1991, 88:5533-5536.
80. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
81. Wang P, Chen J, Zheng A, Nie Y, Shi X, Wang W, Wang G, Luo M, Liu H, Tan L, Song X, Wang Z, Yin X, Qu X, Wang X, Qing T, Ding M, Deng H: Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun 2004, 315:439-444.
82. Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WDJ, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV: CD209L (LSIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 2004, 101:15748-15753.
83. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, Schwartz O, Subbarao K, Nabel GJ: pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 2004, 78:5642-5650.
84. Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J: Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 2003, 31:7117-7130.
85. Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R: Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300:1763-1767.
86. Ziebuhr J, Thiel V, Gorbalenya AE: The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond. J Biol Chem 2001, 276:33220-33232.
87. Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R: Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra {alpha}-helical domain. EMBO J 2002, 21:3213-3224.
88. Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z: The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 2003, 100:13190-13195.
89. Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST: Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A 1999, 96:11000-11007.
90. Chou KC, Wei DQ, Zhong WZ: Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun 2003, 308:148-151.
91. Xiong B, Gui CS, Xu XY, Luo C, Chen J, Luo HB, Chen LL, Li GW, Sun T, Yu CY, Yue LD, Duan WH, Shen JK, Qin L, Shi TL, Li YX, Chen KX, Luo XM, Shen X, Shen JH, Jiang HL: A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. Acta Pharmacol Sin 2003, 24:497-504.
92. Jenwitheesuk E, Samudrala R: Identifying inhibitors of the SARS coronavirus proteinase. Bioorg Med Chem Lett 2003, 13:3989-3992.
93. Klumperman J, Locker JK, Meijer A, Horzinek MC, Geuze HJ, Rottier PJ: Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol 1994, 68:6523-6534.
94. Groneberg DA, Nickolaus M, Springer J, Doring F, Daniel H, Fischer A: Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am J Pathol 2001, 158:707-714.
95. Groneberg DA, Eynott PR, Doring F, Thai Dinh Q, Oates T, Barnes PJ, Chung KF, Daniel H, Fischer A: Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax 2002, 57:55-60.
96. Groneberg DA, Doring F, Eynott PR, Fischer A, Daniel H: Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol 2001, 281:G697-704.
97. Groneberg DA, Doring F, Nickolaus M, Daniel H, Fischer A: Renal assimilation of short chain peptides: visualization of tubular peptide uptake. Pharm Res 2002, 19:1209-1214.
98. Rubio-Aliaga I, Frey I, Boll M, Groneberg DA, Eichinger HM, Balling R, Daniel H: Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney. Mol Cell Biol 2003, 23:3247-3252.
99. Groneberg DA, Doring F, Nickolaus M, Daniel H, Fischer A: Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. Neurosci Lett 2001, 304:181-184.
100. Groneberg DA, Doring F, Theis S, Nickolaus M, Fischer A, Daniel H: Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. Am J Physiol Endocrinol Metab 2002, 282:E1172-9.
101. Ganapathy ME, Huang W, Wang H, Ganapathy V, Leibach FH: Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun 1998, 246:470-475.
102. Sugawara M, Huang W, Fei YJ, Leibach FH, Ganapathy V, Ganapathy ME: Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci 2000, 89:781-789.
103. Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sadee W, Amidon GL: 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res 1998, 15:1154-1159.
104. Theis S, Hartrodt B, Kottra G, Neubert K, Daniel H: Defining minimal structural features in substrates of the H(+)/peptide cotransporter PEPT2 using novel amino acid and dipeptide derivatives. Mol Pharmacol 2002, 61:214-221.
105. Hannon GJ: RNA interference. Nature 2002, 418:244-251.
106. He ML, Zheng B, Peng Y, Peiris JS, Poon LL, Yuen KY, Lin MC, Kung HF, Guan Y: Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA 2003, 290:2665-2666.
107. De Groot AS: How the SARS vaccine effort can learn from HIV - speeding towards the future, learning from the past. Vaccine 2003, 21:4095-4104.
108. Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P: Treatment and vaccines for severe acute respiratory syndrome (SARS). Lancet Infect Dis 2005, In Press:.
109. Brim TA, VanCott JL, Lunney JK, Saif LJ: Cellular immune responses of pigs after primary inoculation with porcine respiratory coronavirus or transmissible gastroenteritis virus and challenge with transmissible gastroenteritis virus. Vet Immunol Immunopathol 1995, 48:35-54.
110. Farsang A, Ros C, Renstrom LHM, Baule C, Soos T, Belak S: Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain. Avian Pathol 2002, 31:229-236.
111. Takamura K, Matsumoto Y, Shimizu Y: Field study of bovine coronavirus vaccine enriched with hemagglutinating antigen for winter dysentery in dairy cows. Can J Vet Res 2002, 66:278-281.
112. Pratelli A, Tinelli A, Decaro N, Cirone F, Elia G, Roperto S, Tempesta M, Buonavoglia C: Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol 2003, 26:151-155.
113. Xiong S, Wang YF, Zhang MY, Liu XJ, Zhang CH, Liu SS, Qian CW, Li JX, Lu JH, Wan ZY, Zheng HY, Yan XG, Meng MJ, Fan JL: Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol Lett 2004, 95:139-143.
114. Ladman BS, Pope CR, Ziegler AF, Swieczkowski T, Callahan JM, Davison S, Gelb Jr. J: Protection of chickens after live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis virus PA/Wolgemuth/98. Avian Dis 2002, 46:938-944.
115. Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B: Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 2004, 101:6641-6646.
116. Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA: Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 2004, 101:2536-2541.
117. He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S: Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004, 324:773-781.
118. Wang X, Schnitzlein WM, Tripathy DN, Girshick T, Khan MI: Construction and immunogenicity studies of recombinant fowl poxvirus containing the S1 gene of Massachusetts 41 strain of infectious bronchitis virus. Avian Dis 46:831-838.
119. Liu C, Kokuho T, Kubota T, Watanabe S, Inumaru S, Yokomizo Y, Onodera T: DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res 2001, 80:75-82.
120. Zhu MS, Pan Y, Chen HQ, Shen Y, Wang XC, Sun YJ, Tao KH: Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 2004, 92:237-243.
121. Kim TW, Lee JH, Hung CF, Peng S, Roden R, Wang MC, Viscidi R, Tsai YC, He L, Chen PJ, Boyd DA, Wu TC: Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 2004, 78:4638-4645.
122. Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ: A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004, 428:561-564.
123. Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E, Andonov A, He R, Li Y, Copps J, Grolla A, Dick D, Berry J, Ganske S, Manning L, Cao J: Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 2004, 78:12672-12676.
124. Koolen MJ, Borst MA, Horzinek MC, Spaan WJ: Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol 1990, 64:6270-6273.
125. Zhang QF, Cui JM, Huang XJ, Lin W, Tan DY, Xu JW, Yang YF, Zhang JQ, Zhang X, Li H, Zheng HY, Chen QX, Yan XG, Zheng K, Wan ZY, Huang JC: Morphology and morphogenesis of severe acute respiratory syndrome (SARS)-associated virus. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003, 35:587-591.